Total Payments
$2,291
2024 Payments
$189.97
Companies
12
Transactions
117
Medicare Patients
3,493
Medicare Billing
$146,703
Payment Breakdown by Category
Food & Beverage$1,730 (75.5%)
Education$561.07 (24.5%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,730 | 109 | 75.5% |
| Education | $561.07 | 8 | 24.5% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Astellas Pharma US Inc | $1,313 | 58 | $0 (2024) |
| PFIZER INC. | $360.73 | 22 | $0 (2024) |
| Bayer Healthcare Pharmaceuticals Inc. | $214.22 | 13 | $0 (2024) |
| Merck Sharp & Dohme LLC | $146.99 | 9 | $0 (2024) |
| UROVANT SCIENCES INC | $102.28 | 5 | $0 (2022) |
| Blue Earth Diagnostics Limited | $30.77 | 2 | $0 (2022) |
| Myovant Sciences Inc. | $29.01 | 2 | $0 (2021) |
| Aytu BioScience, Inc | $24.63 | 2 | $0 (2019) |
| Organogenesis Inc. | $24.11 | 1 | $0 (2024) |
| Endo Pharmaceuticals Inc. | $17.33 | 1 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $189.97 | 10 | PFIZER INC. ($69.51) |
| 2023 | $246.84 | 14 | PFIZER INC. ($102.51) |
| 2022 | $470.20 | 27 | Astellas Pharma US Inc ($188.11) |
| 2021 | $716.88 | 34 | Astellas Pharma US Inc ($509.75) |
| 2020 | $339.25 | 14 | Astellas Pharma US Inc ($313.29) |
| 2019 | $271.47 | 15 | Astellas Pharma US Inc ($185.09) |
| 2018 | $41.92 | 2 | PFIZER INC. ($21.68) |
| 2017 | $14.23 | 1 | Cook Incorporated ($14.23) |
All Payment Transactions
117 individual payment records from CMS Open Payments — Page 1 of 5
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 08/15/2024 | Astellas Pharma US Inc | Xtandi (Drug) | Food and Beverage | In-kind items and services | $21.47 | General |
| Category: Oncology | ||||||
| 07/30/2024 | PFIZER INC. | XTANDI (Drug), ORGOVYX | Food and Beverage | In-kind items and services | $18.89 | General |
| Category: ONCOLOGY | ||||||
| 05/23/2024 | PFIZER INC. | XTANDI (Drug), ORGOVYX | Food and Beverage | In-kind items and services | $15.57 | General |
| Category: ONCOLOGY | ||||||
| 05/14/2024 | Organogenesis Inc. | — | Food and Beverage | In-kind items and services | $24.11 | General |
| 04/30/2024 | Bayer Healthcare Pharmaceuticals Inc. | Nubeqa (Drug) | Food and Beverage | In-kind items and services | $18.65 | General |
| Category: Oncology | ||||||
| 04/16/2024 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological), WELIREG, LYNPARZA | Food and Beverage | In-kind items and services | $17.14 | General |
| Category: ONCOLOGY | ||||||
| 03/26/2024 | PFIZER INC. | XTANDI (Drug), ORGOVYX, TALZENNA | Food and Beverage | In-kind items and services | $14.91 | General |
| Category: ONCOLOGY | ||||||
| 02/29/2024 | PFIZER INC. | PREMARIN (Drug), ESTRING, DUAVEE | Food and Beverage | In-kind items and services | $20.14 | General |
| Category: WOMENS HEALTH | ||||||
| 02/22/2024 | Bayer Healthcare Pharmaceuticals Inc. | Nubeqa (Drug) | Food and Beverage | In-kind items and services | $18.10 | General |
| Category: Oncology | ||||||
| 01/18/2024 | Astellas Pharma US Inc | Xtandi (Drug) | Food and Beverage | In-kind items and services | $20.99 | General |
| Category: Oncology | ||||||
| 12/12/2023 | PFIZER INC. | XTANDI (Drug), ORGOVYX | Food and Beverage | In-kind items and services | $13.67 | General |
| Category: ONCOLOGY | ||||||
| 11/30/2023 | Astellas Pharma US Inc | Xtandi (Drug) | Food and Beverage | In-kind items and services | $19.93 | General |
| Category: Oncology | ||||||
| 11/09/2023 | Bayer Healthcare Pharmaceuticals Inc. | Nubeqa (Drug), Xofigo | Food and Beverage | In-kind items and services | $16.92 | General |
| Category: Oncology | ||||||
| 09/26/2023 | PFIZER INC. | XTANDI (Drug), ORGOVYX, TALZENNA | Food and Beverage | In-kind items and services | $16.77 | General |
| Category: ONCOLOGY | ||||||
| 07/25/2023 | PFIZER INC. | XTANDI (Drug), ORGOVYX, TALZENNA | Food and Beverage | In-kind items and services | $14.56 | General |
| Category: ONCOLOGY | ||||||
| 07/18/2023 | Astellas Pharma US Inc | Xtandi (Drug) | Food and Beverage | In-kind items and services | $18.45 | General |
| Category: Oncology | ||||||
| 06/29/2023 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological), WELIREG, LYNPARZA | Food and Beverage | In-kind items and services | $20.59 | General |
| Category: ONCOLOGY | ||||||
| 05/30/2023 | Bayer Healthcare Pharmaceuticals Inc. | Nubeqa (Drug), Xofigo | Food and Beverage | In-kind items and services | $17.15 | General |
| Category: Oncology | ||||||
| 05/16/2023 | Astellas Pharma US Inc | Myrbetriq (Drug) | Food and Beverage | In-kind items and services | $16.01 | General |
| Category: Urology | ||||||
| 04/25/2023 | PFIZER INC. | PREMARIN (Drug), ESTRING, PAXLOVID | Food and Beverage | In-kind items and services | $19.86 | General |
| Category: WOMENS HEALTH | ||||||
| 03/02/2023 | PFIZER INC. | XTANDI (Drug), ORGOVYX | Food and Beverage | In-kind items and services | $18.18 | General |
| Category: ONCOLOGY | ||||||
| 02/23/2023 | Bayer Healthcare Pharmaceuticals Inc. | Nubeqa (Drug), Xofigo | Food and Beverage | In-kind items and services | $18.64 | General |
| Category: Oncology | ||||||
| 01/10/2023 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological), WELIREG, LYNPARZA | Food and Beverage | In-kind items and services | $16.64 | General |
| Category: ONCOLOGY | ||||||
| 01/05/2023 | PFIZER INC. | XTANDI (Drug), ORGOVYX | Food and Beverage | In-kind items and services | $19.47 | General |
| Category: ONCOLOGY | ||||||
| 12/13/2022 | UROVANT SCIENCES INC | GEMTESA (Drug) | Food and Beverage | Cash or cash equivalent | $22.94 | General |
| Category: Urology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 10 | 811 | 1,003 | $121,311 | $32,500 |
| 2022 | 7 | 892 | 1,153 | $116,039 | $32,700 |
| 2021 | 10 | 991 | 1,386 | $295,560 | $53,439 |
| 2020 | 9 | 799 | 991 | $114,137 | $28,065 |
Total Patients
3,493
Total Services
4,533
Medicare Billing
$146,703
Procedure Codes
36
All Medicare Procedures & Services
36 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 119 | 168 | $22,181 | $13,681 | 61.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 103 | 135 | $12,663 | $7,591 | 60.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 46 | 46 | $11,059 | $5,139 | 46.5% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 31 | 31 | $5,753 | $1,950 | 33.9% |
| 51700 | Simple bladder irrigation and/or instillation | Office | 2023 | 18 | 25 | $16,038 | $1,356 | 8.5% |
| 51798 | Ultrasound measurement of bladder capacity after voiding | Office | 2023 | 126 | 172 | $40,083 | $1,104 | 2.8% |
| 82570 | Creatinine level to test for kidney function or muscle injury | Office | 2023 | 175 | 214 | $1,505 | $1,063 | 70.6% |
| 81001 | Manual urinalysis test with examination using microscope, automated | Office | 2023 | 143 | 161 | $11,228 | $489.54 | 4.4% |
| 81003 | Automated urinalysis test | Office | 2023 | 38 | 39 | $621.00 | $85.80 | 13.8% |
| 81002 | Urinalysis, manual test | Office | 2023 | 12 | 12 | $180.00 | $40.92 | 22.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 104 | 148 | $21,357 | $12,204 | 57.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 135 | 161 | $16,117 | $8,682 | 53.9% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 70 | 70 | $17,010 | $7,002 | 41.2% |
| 82570 | Creatinine level to test for kidney function or muscle injury | Office | 2022 | 228 | 306 | $2,149 | $1,527 | 71.1% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 21 | 21 | $3,255 | $1,481 | 45.5% |
| 81001 | Manual urinalysis test with examination using microscope, automated | Office | 2022 | 226 | 303 | $20,604 | $926.67 | 4.5% |
| 51798 | Ultrasound measurement of bladder capacity after voiding | Office | 2022 | 108 | 144 | $35,547 | $877.08 | 2.5% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 146 | 206 | $28,634 | $18,346 | 64.1% |
| J9217 | Leuprolide acetate (for depot suspension), 7.5 mg | Office | 2021 | 12 | 96 | $158,304 | $13,502 | 8.5% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 109 | 132 | $12,846 | $7,216 | 56.2% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 68 | 68 | $15,776 | $7,069 | 44.8% |
| 99203 | New patient outpatient visit, total time 30-44 minutes | Office | 2021 | 30 | 30 | $4,440 | $2,149 | 48.4% |
| 82570 | Creatinine level to test for kidney function or muscle injury | Office | 2021 | 241 | 326 | $2,296 | $1,637 | 71.3% |
| 51700 | Bladder irrigation and/or instillation | Office | 2021 | 11 | 19 | $12,977 | $1,117 | 8.6% |
| 51798 | Ultrasound measurement of bladder capacity after voiding | Office | 2021 | 125 | 178 | $38,856 | $1,116 | 2.9% |
About Dr. David Meriwether, MD
Dr. David Meriwether, MD is a Urology healthcare provider based in Summersville, West Virginia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/23/2005. The National Provider Identifier (NPI) number assigned to this provider is 1083600191.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. David Meriwether, MD has received a total of $2,291 in payments from pharmaceutical and medical device companies, with $189.97 received in 2024. These payments were reported across 117 transactions from 12 companies. The most common payment nature is "Food and Beverage" ($1,730).
As a Medicare-enrolled provider, Meriwether has provided services to 3,493 Medicare beneficiaries, totaling 4,533 services with total Medicare billing of $146,703. Data is available for 4 years (2020–2023), covering 36 distinct procedure/service records.
Ad
Practice Information
- Specialty Urology
- Location Summersville, WV
- Active Since 09/23/2005
- Last Updated 04/21/2022
- Taxonomy Code 208800000X
- Entity Type Individual
- NPI Number 1083600191
Products in Payments
- XTANDI (Drug) $617.69
- Nubeqa (Drug) $214.22
- Xtandi (Drug) $201.70
- PREMARIN (Drug) $174.58
- KEYTRUDA (Biological) $146.99
- GEMTESA (Drug) $102.28
- Myrbetriq (Drug) $83.26
- MYRBETRIQ (Drug) $40.24
- Axumin (Drug) $30.77
- ORGOVYX (Drug) $29.01
- Natesto (Drug) $24.63
- PVC (Drug) $21.68
- XIAFLEX (Biological) $17.33
- Cook Medical Extractors (Device) $14.23
- UroCuff (Device) $13.13
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.